Introduction L’incidence, la mortalité, la survie et la prévalence sont des indicateurs
épidémiologiques fondamentaux pour évaluer les politiques de santé publique et estimer les …

Background It is not clear whether the administration of radioiodine provides any benefit to
patients with low-risk thyroid cancer after a complete surgical resection. The administration of …

BACKGROUND: The objective of this study was to provide updated estimates of national
trends in cancer incidence and mortality for France for 1980–2005. METHODS: Twenty-five …

Background In patients with low-risk differentiated thyroid cancer undergoing thyroidectomy,
the postoperative administration of radioiodine (iodine-131) is controversial in the absence …

BACKGROUND: Monitoring cancer incidence and mortality time trends is essential for
cancer research and health-care planning. French cancer registries do not cover the entire …

Background Rare cancers pose challenges for diagnosis, treatments, and clinical decision
making. Information about rare cancers is scant. The RARECARE project defined rare …

The thyrotropin receptor (TSHR), a member of the large family of G protein–coupled receptors,
controls both the function and growth of thyroid cells via stimulation of adenylyl cyclase. …

The efficacy of suppressing TSH secretion with levothyroxine (l-T 4 ) in reducing solitary
thyroid nodule growth is still controversial. In this prospective multicenter, randomized, double-…

Context: American Thyroid Association and European Thyroid Association guidelines
cannot recommend for or against radioactive iodine (RAI) ablation after surgery in low-risk …

We present the main results of the first population-based cancers survival study gathering
all French registry data. Survival data on 205,562 cancer cases diagnosed between 01/01/…